Advocacy matters for patients suffering from Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) скачать в хорошем качестве

Advocacy matters for patients suffering from Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

In this interview filmed during EUFOREA's 2nd annual Global Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Awareness Day, EUFOREA Scientific Communications & Advocacy Manager, Elizabeth Van Staeyen, discusses the importance of open dialogue between patients and healthcare providers in order to enact real change for patients suffering from Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and its associated comorbidities. The 2023 Global Awareness Day is supported by an unrestricted educational grant by Sanofi Regeneron. Learn more about EUFOREA's Global Chronic Rhinosinusitis with Nasal Polyps Awareness Day Here: https://www.euforea.eu/events/2023-gl... -------------------------------------------------------------------------------------------------------------------------- Watch the 2023 panel discussion between patients and healthcare providers here:    • #LetsTalkCRS! EUFOREA 2nd Annual Global CR...   -------------------------------------------------------------------------------------------------------------------------- 📽 Subscribe to our YouTube Channel for our latest videos on Allergies and Airway Diseases http://bit.ly/3eMvc3E -------------------------------------------------------------------------------------------------------------------------- 📧 Get in touch with the EUFOREA team for any questions http://bit.ly/2OtlIQp -------------------------------------------------------------------------------------------------------------------------- 📌 EUFOREA is an international non-profit organisation aiming to implement optimal patient care for allergies and airway diseases (asthma, chronic rhinosinusitis, rhinitis) and comorbidities through education, research and advocacy. #euforea 📍Follow us on social media Twitter: http://bit.ly/38wrrM7 LinkedIn: http://bit.ly/2OqtWsf Instagram: http://bit.ly/3TGB5jM ​Facebook: http://bit.ly/3cnNyFF